Effectiveness of Tai Chi vs Cognitive Behavioural Therapy for Insomnia in Middle-Aged and Older Adults
November 27, 2025
Background
Seasonal rhinitis or more commonly known as hay fever is an example of allergic reaction caused by allergens that are usually available in certain seasons. The main causes of this condition are pollen from trees, grasses and weeds and mold spores and dust mite particles. In some regions it is associated with certain plants that produce pollen at certain times of the year. It refers to an inflammation response of the immune system to these non-threatening substances known as allergens. The immune system is triggered to recognize allergens as an enemy and causes inflammation thus the symptoms.Â
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Age GroupÂ
Physical Examination
On examination, children with SARP present with clear manifestations suggestive of inflammation and irritation of the nasal mucosa. It should appear pale, or at times bluish due to lack of oxygen, especially when the person is on a high altitude, swollen and boggy because of congestion. Patients commonly present with significant rhinorrhea or tearing and fre-. there may also be presence of allergic shiners” which are dark circles under the eyes due to venous stasis. Redness of eyes, stringy watery discharge with conjunctival vasodilation or congestion, lacrimation.Â
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-a-non-pharmacological-approach-for-treating-seasonal-allergic-rhinitis
Role of <a class="wpil_keyword_link" href="https://medtigo.com/drug/triamcinolone-intranasal/" title="Intranasal" data-wpil-keyword-link="linked" data-wpil-monitor-id="6414">Intranasal</a> corticosteroids
Role of decongestants
Role of First-generation antihistamines
Diphenhydramine: Inhibition of H1 receptors and the fact that it can pass the blood-brain barrier causing sedative effects. It comes in the form of oral tablets, liquid and chewable. Common administration is 25 to 50 mg every 4 to 6 hours as needed.Â
Chlorpheniramine: It inhibits H1 receptors hence decreases the allergic response. This one has lesser sedative property than diphenhydramine, but it also possesses the ability to cause drowsiness.Â
use-of-intervention-with-a-procedure-in-treating-seasonal-allergic-rhinitis
use-of-phases-in-managing-seasonal-allergic-rhinitis
Seasonal allergic rhinitis care is usually performed in steps to ensure optimal management of the symptoms and increased quality of life. The first is the avoidance where patients are encouraged to avoid contact with the allergens by staying indoors during seasons when the pollens are usually high, using air conditioners and not opening windows. The second phase is the pharmacological phase which is managed using antihistamines for sneezing, itching and runny nose, intranasal steroids for inflammation and congestion, decongestants and leukotriene receptor antagonists. The third phase is immunotherapy, in which allergen specific immunotherapy is administered as an attempt to decrease the immune system’s sensitivity to certain allergens gradually.Â
Medication
Astepro 0.15%-2 sprays in each nostril every day
Astelin 0.1%:1-2 sprays in each nostril every 12 hours
azelastine/fluticasone intranasalÂ
Administer one spray in each nostril twice a day
Treatment: 2 sprays (100mcg of mometasone) in each nostril every day
Prevention: 2 sprays (100mcg of mometasone) in each nostril every day
Use 2-4 weeks before pollen season
Two sprays in each nostril twice a day; may increase to thrice or four times daily if necessary
180mg orally every day or 60mg orally twice a day
Dose Adjustments
Renal Impairment
(CrCl<80ml/min):60mg orally initially every day
Tablet for 12 hour: Take 1 tablet of 60 mg fexofenadine/120 mg pseudoephedrine orally every 12 hours
Tablet for 24 hour: Take 1 tablet of 180 mg fexofenadine/240 mg pseudoephedrine orally once a day
400 to 500mg orally thrice a day
olopatadine intranasal/​mometasone, intranasalÂ
2 sprays per nostril two times a day
Dosage Modifications
Hepatic impairment
Study not carried out
Renal impairment
Study not carried out for mometasone
For olopatadine
Severe at steady state: peak plasma concentration is around 10-fold higher and the area under curve is 2-fold higher
Mild, moderate, or severe: peak plasma concentration remains same for single dose
In every 12 hours use 2 sprays per nostril
60 mg 2 times a day or 180 mg per day with water
A 60 mg dosage is recommended as an initial dosage in patient who have reduced renal function
Astepro 0.15%:
<2 years: Safety and efficacy not established
2 to <6 years: 1 spray in each nostril every 12 hours
6 to 12 years: 1 spray in each nostril every 12 hours
>12 years: 2 sprays in each nostril every day
Astelin 0.1%:
<5 years: Safety and efficacy not established
5 to <12 years: 1 spray in each nostril every 12 hours
>12 years:1-2 sprays in each nostril every 12 hours
azelastine/fluticasone intranasalÂ
<6 years: Safety and efficacy not established
>6 years: Administer one spray in each nostril twice a day
Treatment
>12 years: 2 sprays (100mcg of mometasone) in each nostril every day
2-12 years: 1 spray (50mcg of mometasone) in each nostril every day
<2 years: Safety and efficacy not established
Prevention
<2 years: Safety and efficacy not established
>12 years: 2 sprays (100mcg of mometasone) in each nostril every day
Omnaris-
For <6 years: Safety and efficacy are not seen
For >6 years: 2 sprays per nostril each day (200 mcg/day)
Zetonna-
For <12 years: Safety and efficacy are not seen
For >12 years: 1 spray per nostril each day (74 mcg/day)
<6 years: Safety and Efficacy not established
6 to 14 years: Administer one spray in each nostril thrice a day; 2 sprays in each nostril twice a day
<2 years: Not recommended for usage
Two years to 12 years: 30mg orally twice a day
>12 years: 60mg orally twice a day or 180mg orally every day
Allegra ODT:
Six years to 12 years: 30mg orally twice a day
Dose Adjustments
Renal Impairment
(CrCl<80ml/min)
<6 months: Safety and efficacy not established
Six months to 2 years: 15 mg orally everyday initially
2-12 years: 30 mg orally everyday initially
>12 years: 60 mg orally everyday initially
<12 years: Safety and efficacy not established
>12 years: Tablet for 12 hour: take 1 tablet of 60 mg fexofenadine/120 mg pseudoephedrine orally two times a day
Tablet for 24 hour: take 1 tablet of 180 mg fexofenadine/240 mg pseudoephedrine orally once a day
Renal Impairment
Tablet for 12 hour: take 1 tablet of 60 mg fexofenadine/120 mg pseudoephedrine orally every 24 hours
Tablet for 24 hour: not advised
olopatadine intranasal/​mometasone, intranasalÂ
Safety and efficacy not determined in less than 12 years old
2 sprays per nostril two times a day in more than or equal to 12 years old
Dosage Modifications
Hepatic impairment
Study not carried out
Renal impairment
Study not carried out for mometasone
For olopatadine
Severe at steady state: peak plasma concentration is around 10-fold higher and the area under curve is 2-fold higher
Mild, moderate, or severe: peak plasma concentration remains same for single dose
Safety and efficacy not determined in less than 6 years old
1 spray per nostril every 12 hours in 6 to 12 years old
2 sprays per nostril every 12 hours in more than 12 years old
6 years to 11 years: 30 mg 2 times a day with water
A 30 mg dosage is recommended as an initial dosage in pediatric patient who have reduced renal function
Future Trends
Seasonal rhinitis or more commonly known as hay fever is an example of allergic reaction caused by allergens that are usually available in certain seasons. The main causes of this condition are pollen from trees, grasses and weeds and mold spores and dust mite particles. In some regions it is associated with certain plants that produce pollen at certain times of the year. It refers to an inflammation response of the immune system to these non-threatening substances known as allergens. The immune system is triggered to recognize allergens as an enemy and causes inflammation thus the symptoms.Â
Age GroupÂ
On examination, children with SARP present with clear manifestations suggestive of inflammation and irritation of the nasal mucosa. It should appear pale, or at times bluish due to lack of oxygen, especially when the person is on a high altitude, swollen and boggy because of congestion. Patients commonly present with significant rhinorrhea or tearing and fre-. there may also be presence of allergic shiners” which are dark circles under the eyes due to venous stasis. Redness of eyes, stringy watery discharge with conjunctival vasodilation or congestion, lacrimation.Â
Otolaryngology
Otolaryngology
Otolaryngology
Otolaryngology
Diphenhydramine: Inhibition of H1 receptors and the fact that it can pass the blood-brain barrier causing sedative effects. It comes in the form of oral tablets, liquid and chewable. Common administration is 25 to 50 mg every 4 to 6 hours as needed.Â
Chlorpheniramine: It inhibits H1 receptors hence decreases the allergic response. This one has lesser sedative property than diphenhydramine, but it also possesses the ability to cause drowsiness.Â
Otolaryngology
Otolaryngology
Seasonal allergic rhinitis care is usually performed in steps to ensure optimal management of the symptoms and increased quality of life. The first is the avoidance where patients are encouraged to avoid contact with the allergens by staying indoors during seasons when the pollens are usually high, using air conditioners and not opening windows. The second phase is the pharmacological phase which is managed using antihistamines for sneezing, itching and runny nose, intranasal steroids for inflammation and congestion, decongestants and leukotriene receptor antagonists. The third phase is immunotherapy, in which allergen specific immunotherapy is administered as an attempt to decrease the immune system’s sensitivity to certain allergens gradually.Â
Seasonal rhinitis or more commonly known as hay fever is an example of allergic reaction caused by allergens that are usually available in certain seasons. The main causes of this condition are pollen from trees, grasses and weeds and mold spores and dust mite particles. In some regions it is associated with certain plants that produce pollen at certain times of the year. It refers to an inflammation response of the immune system to these non-threatening substances known as allergens. The immune system is triggered to recognize allergens as an enemy and causes inflammation thus the symptoms.Â
Age GroupÂ
On examination, children with SARP present with clear manifestations suggestive of inflammation and irritation of the nasal mucosa. It should appear pale, or at times bluish due to lack of oxygen, especially when the person is on a high altitude, swollen and boggy because of congestion. Patients commonly present with significant rhinorrhea or tearing and fre-. there may also be presence of allergic shiners” which are dark circles under the eyes due to venous stasis. Redness of eyes, stringy watery discharge with conjunctival vasodilation or congestion, lacrimation.Â
Otolaryngology
Otolaryngology
Otolaryngology
Otolaryngology
Diphenhydramine: Inhibition of H1 receptors and the fact that it can pass the blood-brain barrier causing sedative effects. It comes in the form of oral tablets, liquid and chewable. Common administration is 25 to 50 mg every 4 to 6 hours as needed.Â
Chlorpheniramine: It inhibits H1 receptors hence decreases the allergic response. This one has lesser sedative property than diphenhydramine, but it also possesses the ability to cause drowsiness.Â
Otolaryngology
Otolaryngology
Seasonal allergic rhinitis care is usually performed in steps to ensure optimal management of the symptoms and increased quality of life. The first is the avoidance where patients are encouraged to avoid contact with the allergens by staying indoors during seasons when the pollens are usually high, using air conditioners and not opening windows. The second phase is the pharmacological phase which is managed using antihistamines for sneezing, itching and runny nose, intranasal steroids for inflammation and congestion, decongestants and leukotriene receptor antagonists. The third phase is immunotherapy, in which allergen specific immunotherapy is administered as an attempt to decrease the immune system’s sensitivity to certain allergens gradually.Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
